GS vs TARA · P/E 20, rev $37.56B vs $228.8M cap
Goldman Sachs Group Inc (GS) versus Protara Therapeutics Inc (TARA) — a side-by-side from cached financials, not a winner call.
Goldman Sachs Group Inc (GS) is a capital markets company listed on NYSE. It is led by David Solomon.
Protara Therapeutics Inc (TARA) is a biotechnology company listed on NASDAQ.
Latest reported GS revenue for 2026-06-30 was $37.56B. Net income was $12.26B. GS currently screens at market cap $324.25B and trailing P/E 20.1.
TARA does not have a complete income-statement cache yet.
GS currently screens at market cap $324.25B and trailing P/E 20.1. TARA currently screens at market cap $228.8M.
Not investment advice. Open the GS and TARA stock pages for the full models.
Not investment advice.